Magnetar Financial’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Magnetar Financial’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-500,172	Closed	-$5.13M	–	758
2023 Q1	$5.13M	Sell	500,172 -14,555	-3%	-$148K	0.1%	156
2022 Q4	$5.17M	Hold	514,727	–	–	0.09%	224
2022 Q3	$5.08M	Buy	514,727 +492,000	+2,165%	+$4.83M	0.07%	309
2022 Q2	$221	Buy	+22,727	New	+$222K	﹤0.01%	1290

Magnetar Financial's ORIA Position: Q2 2023 in Review

Magnetar Financial sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 500,172 shares — an estimated $5.13M sold.

Magnetar Financial first reported a position in ORIA in Q2 2022 and held it in 4 quarters. The position peaked at $5.17M in Q4 2022. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Magnetar Financial reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Magnetar Financial sold 500,172 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $5.13M.
Magnetar Financial first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q2 2022 and held it in 4 quarters.
Magnetar Financial's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $5.17M in Q4 2022.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Magnetar Financial's 13F filing for Q2 2023, filed 11 Aug 2023.